OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Polymorphism of the HLA system and weak antibody response to BNT162b2 mRNA vaccine
Roberto Crocchiolo, Anna Maria Gallina, Arianna Pani, et al.
HLA (2022) Vol. 99, Iss. 3, pp. 183-191
Closed Access | Times Cited: 22
Roberto Crocchiolo, Anna Maria Gallina, Arianna Pani, et al.
HLA (2022) Vol. 99, Iss. 3, pp. 183-191
Closed Access | Times Cited: 22
Showing 22 citing articles:
GNB3 c.825c>T polymorphism influences T-cell but not antibody response following vaccination with the mRNA-1273 vaccine
Ieva Čiučiulkaitė, Birte Möhlendick, Laura Thümmler, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 132
Ieva Čiučiulkaitė, Birte Möhlendick, Laura Thümmler, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 132
Lynch syndrome cancer vaccines: A roadmap for the development of precision immunoprevention strategies
Shizuko Sei, Aysel Ahadova, Derin B. Keskin, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 16
Shizuko Sei, Aysel Ahadova, Derin B. Keskin, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 16
HLA Variation and SARS-CoV-2 Specific Antibody Response
Dawit Wolday, Chun Yiu Jordan Fung, Gregory Morgan, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 906-906
Open Access | Times Cited: 16
Dawit Wolday, Chun Yiu Jordan Fung, Gregory Morgan, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 906-906
Open Access | Times Cited: 16
The Effect of HLA Polymorphism on Immune Response to SARS ‐CoV ‐2 Vaccination Within an Infection‐Naïve, Vulnerable Population With End‐Stage Renal Disease
F. Shinewi May Erskine, Katrina Spensley, Maria Prendecki, et al.
HLA (2025) Vol. 105, Iss. 2
Open Access
F. Shinewi May Erskine, Katrina Spensley, Maria Prendecki, et al.
HLA (2025) Vol. 105, Iss. 2
Open Access
The humoral and cellular response to mRNA SARS‐CoV ‐2 vaccine is influenced by HLA polymorphisms
Francesca Bertinetto, Paola Magistroni, G. Mazzola, et al.
HLA (2023) Vol. 102, Iss. 3, pp. 301-315
Open Access | Times Cited: 14
Francesca Bertinetto, Paola Magistroni, G. Mazzola, et al.
HLA (2023) Vol. 102, Iss. 3, pp. 301-315
Open Access | Times Cited: 14
HLA-DQB1*05:03 is associated with an increased risk of COVID-19 progression in the Bulgarian population
Tsvetelin Lukanov, Anastasiya Mihaylova, Bushra Al Hadra, et al.
Human Immunology (2025) Vol. 86, Iss. 1, pp. 111228-111228
Closed Access
Tsvetelin Lukanov, Anastasiya Mihaylova, Bushra Al Hadra, et al.
Human Immunology (2025) Vol. 86, Iss. 1, pp. 111228-111228
Closed Access
Host genetics impact on SARS-CoV-2 vaccine-induced immunoglobulin levels and dynamics: The role of TP53, ABO, APOE, ACE2, HLA-A, and CRP genes
Donato Gemmati, Giovanna Longo, Ines Gallo, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 17
Donato Gemmati, Giovanna Longo, Ines Gallo, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 17
Genome‐wide association studies of response and side effects to the BNT162b2 vaccine in Italian healthcare workers: Increased antibody levels and side effects in carriers of the HLA‐A*03:01 allele
Chiara Magri, Eleonora Marchina, Emanuele Sansone, et al.
HLA (2023) Vol. 102, Iss. 6, pp. 707-719
Open Access | Times Cited: 10
Chiara Magri, Eleonora Marchina, Emanuele Sansone, et al.
HLA (2023) Vol. 102, Iss. 6, pp. 707-719
Open Access | Times Cited: 10
Spotlight on mycobacterial lipid exploitation using nanotechnology for diagnosis, vaccines, and treatments
Carlos M. Valdemar-Aguilar, Ravichandran Manisekaran, Laura Susana Acosta‐Torres, et al.
Nanomedicine Nanotechnology Biology and Medicine (2023) Vol. 48, pp. 102653-102653
Open Access | Times Cited: 7
Carlos M. Valdemar-Aguilar, Ravichandran Manisekaran, Laura Susana Acosta‐Torres, et al.
Nanomedicine Nanotechnology Biology and Medicine (2023) Vol. 48, pp. 102653-102653
Open Access | Times Cited: 7
Spotlight on contributory role of host immunogenetic profiling in SARS-CoV-2 infection: Susceptibility, severity, mortality, and vaccine effectiveness
Somayeh Yazdanparast, Mehdi Bakhtiyaridovvombaygi, Fatemeh Mikanik, et al.
Life Sciences (2023) Vol. 328, pp. 121907-121907
Open Access | Times Cited: 7
Somayeh Yazdanparast, Mehdi Bakhtiyaridovvombaygi, Fatemeh Mikanik, et al.
Life Sciences (2023) Vol. 328, pp. 121907-121907
Open Access | Times Cited: 7
Don’t blame the messenger: lessons learned for cancer mRNA vaccines during the COVID-19 pandemic
Van K. Morris, Scott Kopetz
Nature reviews. Cancer (2022) Vol. 22, Iss. 6, pp. 317-318
Open Access | Times Cited: 11
Van K. Morris, Scott Kopetz
Nature reviews. Cancer (2022) Vol. 22, Iss. 6, pp. 317-318
Open Access | Times Cited: 11
Is HLA type a possible cancer risk modifier in Lynch syndrome?
Aysel Ahadova, Johannes Witt, Saskia Haupt, et al.
International Journal of Cancer (2022) Vol. 152, Iss. 10, pp. 2024-2031
Open Access | Times Cited: 10
Aysel Ahadova, Johannes Witt, Saskia Haupt, et al.
International Journal of Cancer (2022) Vol. 152, Iss. 10, pp. 2024-2031
Open Access | Times Cited: 10
Strong humoral response after Covid‐19 vaccination correlates with the common HLA allele A*03:01 and protection from breakthrough infection
Roberto Crocchiolo, Coralie Frassati, Anna Maria Gallina, et al.
HLA (2024) Vol. 103, Iss. 3
Closed Access | Times Cited: 1
Roberto Crocchiolo, Coralie Frassati, Anna Maria Gallina, et al.
HLA (2024) Vol. 103, Iss. 3
Closed Access | Times Cited: 1
Genomic characterization of HLA class I and class II genes in ethnically diverse sub‐Saharan African populations: A report on novel HLA alleles
Ioanna Pagkrati, Jamie L. Duke, Eric Mbunwe, et al.
HLA (2023) Vol. 102, Iss. 2, pp. 192-205
Open Access | Times Cited: 4
Ioanna Pagkrati, Jamie L. Duke, Eric Mbunwe, et al.
HLA (2023) Vol. 102, Iss. 2, pp. 192-205
Open Access | Times Cited: 4
Bibliometric analysis of RNA vaccines for cancer
Yang Xue, Jian Kang, Zhaohui Xing, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 4
Yang Xue, Jian Kang, Zhaohui Xing, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 4
Association between SARS-CoV-2 Symptoms, Ct Values, and Serological Response in Vaccinated and Unvaccinated Healthcare Personnel
Christopher W Farnsworth, Caroline A. O’Neil, Claire Dalton, et al.
The Journal of Applied Laboratory Medicine (2023) Vol. 8, Iss. 5, pp. 871-886
Closed Access | Times Cited: 2
Christopher W Farnsworth, Caroline A. O’Neil, Claire Dalton, et al.
The Journal of Applied Laboratory Medicine (2023) Vol. 8, Iss. 5, pp. 871-886
Closed Access | Times Cited: 2
Immune response stability to the SARS-CoV-2 mRNA vaccine booster is influenced by differential splicing of HLA genes
Cíntia Barros Santos-Rebouças, Cristina dos Santos Ferreira, Jeane de Souza Nogueira, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Cíntia Barros Santos-Rebouças, Cristina dos Santos Ferreira, Jeane de Souza Nogueira, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Current Progress in Genomic and Genetic Research on Human Viral Diseases
Binhua Liang, Birte Möhlendick, Hezhao Ji, et al.
Frontiers research topics (2024)
Open Access
Binhua Liang, Birte Möhlendick, Hezhao Ji, et al.
Frontiers research topics (2024)
Open Access
How could our genetics impact COVID-19 vaccine response?
Keyi Zheng, Amanda Y. Chong, Alexander J. Mentzer
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 9, pp. 1027-1039
Closed Access
Keyi Zheng, Amanda Y. Chong, Alexander J. Mentzer
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 9, pp. 1027-1039
Closed Access
Association of human leucocyte antigen loci with vaccine‐induced immune thrombotic thrombocytopenia: Potential role of the interaction between platelet factor 4‐derived peptides and MHC ‐II
Eleonora Petito, Loredana Bury, Lilian Antunes Heck, et al.
British Journal of Haematology (2024)
Open Access
Eleonora Petito, Loredana Bury, Lilian Antunes Heck, et al.
British Journal of Haematology (2024)
Open Access
Influence of the Single Nucleotide Polymorphisms rs12252 and rs34481144 in IFITM3 on the Antibody Response after Vaccination against COVID-19
Ieva Čiučiulkaitė, Winfried Siffert, Carina Elsner, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1257-1257
Open Access | Times Cited: 1
Ieva Čiučiulkaitė, Winfried Siffert, Carina Elsner, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1257-1257
Open Access | Times Cited: 1
SARS-CoV-2 immune response and reinfection in vaccinated Maya and mestizo in Southeast of Mexico
Vı́ctor Monteón, Floribeth León-Pérez, Josefina G Ancona-León, et al.
Salud Pública de México (2023) Vol. 66, Iss. 1, ene-feb, pp. 14-16
Open Access | Times Cited: 1
Vı́ctor Monteón, Floribeth León-Pérez, Josefina G Ancona-León, et al.
Salud Pública de México (2023) Vol. 66, Iss. 1, ene-feb, pp. 14-16
Open Access | Times Cited: 1
